Antidepressants and Sexual Health – How to Improve Patients’ Quality of Life?
DOI:
https://doi.org/10.12923/2353-8627/2025-0010Keywords:
SSRI, antidepressants, sexual dysfunction, alternative treatmentAbstract
Introduction: Depression is one of the most common psychiatric disorders, with its prevalence continuously increasing. Consequently, more individuals are using antidepressants and experiencing various adverse effects. One of the important, yet often overlooked, side effect of depression pharmacotherapy is sexual dysfunction. This article aims to review sexual dysfunction associated with antidepressant therapy, explore available management strategies, and highlight emerging therapeutic options.
Materials and methods: A literature review was performed using the PubMed and Scopus databases, covering publications from 2020 to 2024 focused on antidepressant-induced sexual dysfunction. Open-access publications in English-language were included, comprising original research articles, systematic reviews, meta-analyses, and narrative reviews.
Results: The most frequently reported antidepressant-related sexual dysfunctions include decreased libido, delayed ejaculation, anorgasmia, and erectile dysfunction. These effects are most often observed in patients treated with selective serotonin reuptake inhibitors (SSRIs) and serotonin-norepinephrine reuptake inhibitors (SNRIs). A lower, though still relevant, risk is associated with tricyclic antidepressants (TCAs) and monoamine oxidase inhibitors (MAOIs). Medications such as vortioxetine, agomelatine, vilazodone, and bupropion offer promising therapeutic alternatives with a reduced risk of sexual side effects. Moreover, growing evidence supports the effectiveness of adjunctive and non-pharmacological interventions.
Conclusions: Sexual dysfunctions significantly impair patients’ quality of life and often lead to treatment discontinuation and recurrence of depressive symptoms. Despite their prevalence, many patients do not report these symptoms due to embarrassment, which underscores the need for a conscious, empathetic approach from doctors. Active monitoring and implementing effective strategies to minimise these side effects without compromising antidepressant efficacy are essential.
References
1. Rothmore J. Antidepressant-induced sexual dysfunction. Med J Aust. 2020 Apr;212(7):329-34.
2. Montejo AL, Llorca G, Izquierdo JA, Rico-Villademoros F. Incidence of sexual dysfunction associated with antidepressant agents: a prospective multicenter study of 1022 outpatients. Spanish Working Group for the Study of Psychotropic-Related Sexual Dysfunction. J Clin Psychiatry. 2001;62 Suppl 3:10-21.
3. Atmaca M. Selective Serotonin Reuptake Inhibitor-Induced Sexual Dysfunction: Current Management Perspectives. Neuropsychiatr Dis Treat. 2020 Apr 20;16:1043-50.
4. Rochester MP, Kane AM, Linnebur SA, Fixen DR. Evaluating the risk of QTc prolongation associated with antidepressant use in older adults: a review of the evidence. Ther Adv Drug Saf. 2018 Jun;9(6):297-308.
5. Hamer M, Batty GD, Seldenrijk A, Kivimaki M. Antidepressant medication use and future risk of cardiovascular disease: the Scottish Health Survey. Eur Heart J. 2011 Feb;32(4):437-42.
6. Jang HY, Kim JH, Song Y-K, Shin J-Y, Lee H-Y, Ahn YM, et al. Antidepressant use and the risk of major adverse cardiovascular events in patients without known cardiovascular disease: A retrospective cohort study. Front Pharmacol. 2020 Dec 10;11:594474.
7. Bixby AL, VandenBerg A, Bostwick JR. Clinical management of bleeding risk with antidepressants. Ann Pharmacother. 2019 Feb;53(2):186-94.
8. Rahman AA, Platt RW, Beradid S, Boivin J-F, Rej S, Renoux C. Concomitant use of selective serotonin reuptake inhibitors with oral anticoagulants and risk of major bleeding. JAMA Netw Open. 2024 Mar 4;7(3):e243208.
9. Stachowicz K, Sowa-Kućma M. The treatment of depression -searching for new ideas. Front Pharmacol. 2022 Oct 7;13:988648.
10. Braund TA, Tillman G, Palmer DM, Gordon E, Rush AJ, Harris AWF. Antidepressant side effects and their impact on treatment outcome in people with major depressive disorder: an iSPOT-D report. Transl Psychiatry. 2021 Aug 4;11(1):417.
11. Saha K, Torous J, Kiciman E, De Choudhury M. Understanding Side Effects of Antidepressants: Large-scale Longitudinal Study on Social Media Data. JMIR Ment Health. 2021 Mar 19;8(3):e26589.
12. Jupe T, Giannopoulos I, Roumpou A. Sexual dysfunction, depression, and the impact of antidepressants. Eur Psychiatry. 2024 Apr;67(S1):S539-40.
13. Jing E, Straw-Wilson K. Sexual dysfunction in selective serotonin reuptake inhibitors (SSRIs) and potential solutions: A narrative literature review. Ment Health Clin. 2016 Jul;6(4):191-6.
14. Grover S, Kate N, Mishra E, Avasthi A. Prevalence and type of sexual dysfunction in female patients receiving antidepressant medications. Journal of Psychosexual Health. 2020 Apr;2(2):158-64.
15. Zeiss R, Malejko K, Connemann B, Gahr M, Durner V, Graf H. Sexual Dysfunction Induced by Antidepressants-A Pharmacovigilance Study Using Data from VigiBaseTM. Pharmaceuticals (Basel). 2024 Jun 24;17(7).
16. AlBreiki M, AlMaqbali M, AlRisi K, AlSinawi H, Al Balushi M, Al Zakwani W. Prevalence of antidepressant-induced sexual dysfunction among psychiatric outpatients attending a tertiary care hospital. Neurosciences (Riyadh). 2020 Jan;25(1):55-60.
17. Edinoff AN, Akuly HA, Hanna TA, Ochoa CO, Patti SJ, Ghaffar YA, et al. Selective serotonin reuptake inhibitors and adverse effects: A narrative review. Neurol Int. 2021 Aug 5;13(3):387-401.
18. Chu A, Wadhwa R. Selective serotonin reuptake inhibitors. StatPearls. Treasure Island (FL): StatPearls Publishing; 2025.
19. Hjorth OR, Frick A, Gingnell M, Hoppe JM, Faria V, Hultberg S, et al. Expectancy effects on serotonin and dopamine transporters during SSRI treatment of social anxiety disorder: a randomized clinical trial. Transl Psychiatry. 2021 Nov 3;11(1):559.
20. Anagha K, Shihabudheen P, Uvais NA. Side Effect Profiles of Selective Serotonin Reuptake Inhibitors: A Cross-Sectional Study in a Naturalistic Setting. Prim Care Companion CNS Disord. 2021 Jul 29;23(4).
21. Singh HK, Saadabadi A. Sertraline. StatPearls. Treasure Island (FL): StatPearls Publishing; 2025.
22. Dong L, Xie Y, Zou X. Association between sleep duration and depression in US adults: A cross-sectional study. J Affect Disord. 2022 Jan 1;296:183-8.
23. Aarts N, Zuurbier LA, Noordam R, Hofman A, Tiemeier H, Stricker BH, et al. Use of Selective Serotonin Reuptake Inhibitors and Sleep Quality: A Population-Based Study. J Clin Sleep Med. 2016 Jul 15;12(7):989-95.
24. Klaas S, Siva JB, Bak M, Govers M, Schreiber R. The pathophysiology of Post SSRI Sexual Dysfunction - Lessons from a case study. Biomed Pharmacother. 2023 May;161:114166.
25. Xu J, He K, Zhou Y, Zhao L, Lin Y, Huang Z, et al. The effect of SSRIs on Semen quality: A systematic review and meta-analysis. Front Pharmacol. 2022 Sep 14;13:911489.
26. Santos RA, Sousa AP, Almeida-Santos T, Ramalho-Santos J, Tavares RS. In vitro effects of antidepressants on human sperm function. Asian J Androl. 2025 Jan 1;27(1):30-6.
27. Elnazer HY, Baldwin DS. Treatment with citalopram, but not with agomelatine, adversely affects sperm parameters: a case report and translational review. Acta Neuropsychiatr. 2014 Apr;26(2):125-9.
28. Tanrikut C, Schlegel PN. Antidepressant-associated changes in semen parameters. Urology. 2007 Jan 1;69(1):185.e5-7.
29. Hashemi-Mohammadabad N, Taghavi S-A, Lambert N, Moshtaghi R, Bazarganipour F, Sharifi M. Adjuvant administration of probiotic effects on sexual function in depressant women undergoing SSRIs treatment: a double-blinded randomized controlled trial. BMC Psychiatry. 2024 Jan 12;24(1):44.
30. Singh D, Saadabadi A. Venlafaxine. StatPearls. Treasure Island (FL): StatPearls Publishing; 2018.
31. Shelton RC. Serotonin and norepinephrine reuptake inhibitors. Handb Exp Pharmacol. 2019;250:145-80.
32. Hieronymus F, Lisinski A, Eriksson E, Østergaard SD. Do side effects of antidepressants impact efficacy estimates based on the Hamilton Depression Rating Scale? A pooled patient-level analysis. Transl Psychiatry. 2021 Apr 27;11(1):249.
33. Biyikoglu M, Kettas E, Sesli M, Senel S, Cayan S, Akbay E. The effect of duloxetine on female sexual functions in the treatment of stress incontinence. Arch Gynecol Obstet. 2023 Sep;308(3):1037-42.
34. Moraczewski J, Awosika AO, Aedma KK. Tricyclic Antidepressants. StatPearls. Treasure Island (FL): StatPearls Publishing; 2025.
35. Khalid MM, Waseem M. Tricyclic Antidepressant Toxicity. StatPearls. Treasure Island (FL): StatPearls Publishing; 2025.
36. Bonilla-Jaime H, Sánchez-Salcedo JA, Estevez-Cabrera MM, Molina-Jiménez T, Cortes-Altamirano JL, Alfaro-Rodríguez A. Depression and pain: use of antidepressants. Curr Neuropharmacol. 2022;20(2):384-402.
37. Wang Q, Xu Z, Chen X, Liu L, Liu X. Effect of antidepressants on ejaculation dysfunction in patients with depression and anxiety: A systematic review and network meta-analysis. Andrology. 2024 Sep 30;
38. Leutzendorff A, Al Jalali V, Bauer M, Minichmayr IK, Reiter B, Duchek MW-, et al. Single-dose and steady-state pharmacokinetics of clomipramine, yohimbine and clomipramine/yohimbine combination: A clinical drug-drug interaction study. Br J Clin Pharmacol. 2024 Oct 21;
39. Sub Laban T, Saadabadi A. Monoamine oxidase inhibitors (MAOI). StatPearls. Treasure Island (FL): StatPearls Publishing; 2024.
40. Edinoff AN, Swinford CR, Odisho AS, Burroughs CR, Stark CW, Raslan WA, et al. Clinically Relevant Drug Interactions with Monoamine Oxidase Inhibitors. Health Psychol Res. 2022 Nov 3;10(4):39576.
41. Birkenhager TK, Heijnen WT. Monoamine oxidase inhibitors: Seriously underused in the treatment of major depression. Acta Psychiatr Scand. 2024 Dec;150(6):497-9.
42. Beeder LA, Samplaski MK. Effect of antidepressant medications on semen parameters and male fertility. Int J Urol. 2020 Jan;27(1):39-46.
43. Kiani C. Tranylcypromine: its pharmacology, safety, and efficacy. American Journal of Psychiatry Residents’ Journal. 2020 Jun 16;15(4):3-5.
44. Fagiolini A, González Pinto A, Miskowiak KW, Morgado P, Young AH, Vieta E. Trazodone in the Management of Major Depression Among Elderly Patients with Dementia: A Narrative Review and Clinical Insights. Neuropsychiatr Dis Treat. 2023 Dec 21;19:2817-31.
45. Fagiolini A, González-Pinto A, Miskowiak KW, Morgado P, Young AH, Vieta E. Role of trazodone in treatment of major depressive disorder: an update. Ann Gen Psychiatry. 2023 Sep 2;22(1):32.
46. Rosso G, Benatti B, Pettorruso M, Sampogna G, Tomasetti C. Case report: Personalizing the use of trazodone in real-world patients: a study of three cases of depression with comorbidities. Front Psychiatry. 2024 Aug 29;15:1362221.
47. Coin A, Noale M, Gareri P, Trevisan C, Bellio A, Fini F, et al. Clinical profile of trazodone users in a multisetting older population: data from the Italian GeroCovid Observational study. Eur Geriatr Med. 2023 Jun;14(3):465-76.
48. Silberman M, Hu EW. Priapism. StatPearls. Treasure Island (FL): StatPearls Publishing; 2017.
49. Kashfi S, Loloi J, Statnii I, Arifi B, Sharma S. Gabapentin-Induced Priapism. Cureus. 2022 Jan 14;14(1):e21241.
50. Tripathi A, Agrawal A, Joshi M. Treatment-emergent sexual dysfunctions due to antidepressants: A primer on assessment and management strategies. Indian J Psychiatry. 2024 Mar 18;66(3):293-303.
51. Van Cauwenberghe J, Enzlin P, Nefs G, Ruige J, Hendrieckx C, De Block C, et al. Prevalence of and risk factors for sexual dysfunctions in adults with type 1 or type 2 diabetes: Results from Diabetes MILES - Flanders. Diabet Med. 2022 Jan;39(1):e14676.
52. Lou IX, Chen J, Ali K, Chen Q. Relationship between hypertension, antihypertensive drugs and sexual dysfunction in men and women: A literature review. Vasc Health Risk Manag. 2023 Nov 3;19:691-705.
53. McNabney SM, Gletsu-Miller N, Rowland DL. Sexual function and satisfaction in the context of obesity. Curr Diab Rep. 2023 Nov;23(11):315-27.
54. Bates JN, Kohn TP, Pastuszak AW. Effect of thyroid hormone derangements on sexual function in men and women. Sex Med Rev. 2020 Apr;8(2):217-30.
55. Kałużna M, Kompf P, Rabijewski M, Moczko J, Kałużny J, Ziemnicka K, et al. Reduced quality of life and sexual satisfaction in isolated hypogonadotropic hypogonadism. J Clin Med. 2021 Jun 14;10(12).
56. David K, De Vincentis S, Antonio L. Impact of hyperprolactinemia on sexual function. J Sex Med. 2024 Feb 27;21(3):197-9.
57. Hicks CW, Wang D, Windham BG, Selvin E. Association of Peripheral Neuropathy with Erectile Dysfunction in US Men. Am J Med. 2021 Feb;134(2):282-4.
58. Herder T, Spoelstra SK, Peters AWM, Knegtering H. Sexual dysfunction related to psychiatric disorders: a systematic review. J Sex Med. 2023 Jun 28;20(7):965-76.
59. Omolaoye TS, Halabi MO, Mubarak M, Cyril AC, Duvuru R, Radhakrishnan R, et al. Statins and male fertility: is there a cause for concern? Toxics. 2022 Oct 20;10(10).
60. Hamed SA. Sexual dysfunctions induced by pregabalin. Clin Neuropharmacol. 2018;41(4):116-22.
61. García-Blanco A, García-Portilla MP, Fuente-Tomás L de la, Batalla M, Sánchez-Autet M, Arranz B, et al. Sexual Dysfunction and Mood Stabilizers in Long-Term Stable Patients With Bipolar Disorder. J Sex Med. 2020 May;17(5):930-40.
62. Ghosh A, Kathiravan S, Sharma K, Mattoo SK. A scoping review of the prevalence and correlates of sexual dysfunction in adults with substance use disorders. J Sex Med. 2022 Feb;19(2):216-33.
63. Montejo AL, Prieto N, de Alarcón R, Casado-Espada N, de la Iglesia J, Montejo L. Management Strategies for Antidepressant-Related Sexual Dysfunction: A Clinical Approach. J Clin Med. 2019 Oct 7;8(10).
64. Sørensen A, Juhl Jørgensen K, Munkholm K. Clinical practice guideline recommendations on tapering and discontinuing antidepressants for depression: a systematic review. Ther Adv Psychopharmacol. 2022 Feb 11;12:20451253211067656.
65. Lalegani E, Eissazade N, Shalbafan M, Salehian R, Shariat SV, Askari S, et al. Safety and Efficacy of Drug Holidays for Women with Sexual Dysfunction Induced by Selective Serotonin Reuptake Inhibitors (SSRIs) Other than Fluoxetine: An Open-Label Randomized Clinical Trial. Brain Sci. 2023 Sep 30;13(10).
66. Alipour-Kivi A, Eissazade N, Shariat SV, Salehian R, Soraya S, Askari S, et al. The effect of drug holidays on sexual dysfunction in men treated with selective serotonin reuptake inhibitors (SSRIs) other than fluoxetine: an 8-week open-label randomized clinical trial. BMC Psychiatry. 2024 Jan 23;24(1):67.
67. Jacobsen PL, Nomikos GG, Zhong W, Cutler AJ, Affinito J, Clayton A. Clinical implications of directly switching antidepressants in well-treated depressed patients with treatment-emergent sexual dysfunction: a comparison between vortioxetine and escitalopram. CNS Spectr. 2020 Feb;25(1):50-63.
68. Montejo AL, Sánchez-Sánchez F, De Alarcón R, Matías J, Cortés B, Matos C, et al. Switching to Vortioxetine in Patients with Poorly Tolerated Antidepressant-Related Sexual Dysfunction in Clinical Practice: A 3-Month Prospective Real-Life Study. J Clin Med. 2024 Jan 18;13(2).
69. Huang J, Xie X-M, Lyu N, Fu B-B, Zhao Q, Zhang L, et al. Agomelatine in the treatment of anhedonia, somatic symptoms, and sexual dysfunction in major depressive disorder. Front Psychiatry. 2023 Apr 20;14:1115008.
70. Bathla M, Anjum S. A 12-week prospective randomized controlled comparative trial of vilazodone and sertraline in Indian patients with depression. Indian J Pharmacol. 2020 Feb;52(1):10-5.
71. Razali NA, Sidi H, Choy CL, Roos NAC, Baharudin A, Das S. The Role of Bupropion in the Treatment of Women with Sexual Desire Disorder: A Systematic Review and Meta-Analysis. Curr Neuropharmacol. 2022;20(10):1941-55.
72. Trinchieri M, Trinchieri M, Perletti G, Magri V, Stamatiou K, Cai T, et al. Erectile and Ejaculatory Dysfunction Associated with Use of Psychotropic Drugs: A Systematic Review. J Sex Med. 2021 Aug;18(8):1354-63.
73. Dhaliwal A, Gupta M. PDE5 Inhibitors. StatPearls. Treasure Island (FL): StatPearls Publishing; 2025.
74. Wibowo DNSA, Soebadi DM, Soebadi MA. Yohimbine as a treatment for erectile dysfunction: A systematic review and meta-analysis. Turk J Urol. 2021 Nov;47(6):482-8.
75. Nowacka A, Śniegocka M, Śniegocki M, Ziółkowska E, Bożiłow D, Smuczyński W. Multifaced Nature of Yohimbine-A Promising Therapeutic Potential or a Risk? Int J Mol Sci. 2024 Nov 29;25(23).
76. Goyal A, Raza FA, Sulaiman SA, Shahzad A, Aaqil SI, Iqbal M, et al. Saffron extract as an emerging novel therapeutic option in reproduction and sexual health: recent advances and future prospectives. Ann Med Surg (Lond). 2024 May;86(5):2856-65.
77. Concerto C, Rodolico A, Meo V, Chiappetta D, Bonelli M, Mineo L, et al. A Systematic Review on the Effect of Nutraceuticals on Antidepressant-Induced Sexual Dysfunctions: From Basic Principles to Clinical Applications. Curr Issues Mol Biol. 2022 Jul 25;44(8):3335-50.
78. Shahmoradi N, Davarinejad O, Brühl AB, Brand S. Effects of Aphrodite (an Herbal Compound) on SSRI-Induced Sexual Dysfunctions and Depression in Females with Major Depressive Disorder: Findings from a Randomized Clinical Trial. Medicina (Kaunas). 2023 Sep 14;59(9).
79. Brotto LA, Altas M. New management approaches for female sexual dysfunction. Curr Opin Obstet Gynecol. 2024 Oct 1;36(5):372-7.
80. Anderson D, Laforge J, Ross MM, Vanlangendonck R, Hasoon J, Viswanath O, et al. Male Sexual Dysfunction. Health Psychol Res. 2022 Aug 20;10(3):37533.
81. Khera M, Bhattacharyya S, Miller LE. Effect of aerobic exercise on erectile function: systematic review and meta-analysis of randomized controlled trials. J Sex Med. 2023 Nov 30;20(12):1369-75.
82. Maseroli E, Rastrelli G, Di Stasi V, Cipriani S, Scavello I, Todisco T, et al. Physical activity and female sexual dysfunction: A lot helps, but not too much. J Sex Med. 2021 Jul;18(7):1217-29.
83. Mohammad-Abad NH, Zafari S, Taghavi S-A, Zafari F, Karimi E, Hosseini A, et al. Acupressure as an Effective Method for Improving Sexual Function in Depressant Women Treated with Selective Serotonin Reuptake Inhibitor: a Randomized Clinical Trial. J Acupunct Meridian Stud. 2024 Dec 31;17(6):196-205.
Downloads
Published
Issue
Section
License
Copyright (c) 2025 Weronika Maria Woźniak, Katarzyna Wiktoria Witczak, Zuzanna Winiarska, Marcin Wieleba, Ewelina Anna Soroka (Autor)
This work is licensed under a Creative Commons Attribution 4.0 International License.
